Filing Details

Accession Number:
0001144204-11-052179
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-09-09 16:43:45
Reporting Period:
2011-09-06
Filing Date:
2011-09-09
Accepted Time:
2011-09-09 16:43:45
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1175151 Cytosorbents Corp CTSO Surgical & Medical Instruments & Apparatus (3841) 980373793
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1368153 David Lamadrid C/O Cytosorbents Corp.
7 Deer Park Drive, Suite K
Monmouth Junction NJ 08852
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2011-09-06 12,500 $0.22 7,837,500 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option Disposition 2011-09-06 12,500 $0.00 12,500 $0.04
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
7,837,500 2011-09-06 No 4 M Direct
Footnotes
  1. The shares of common stock were sold by Mr. Lamadrid pursuant to a 10b5-1 trading plan, adopted by the reporting person on June 8, 2011.
  2. In addition to the currently outstanding shares of common stock owned by Mr. Lamadrid and reported here, Mr. Lamadrid also beneficially owns the shares of common stock underlying the following stock options: options to purchase 150,000 shares of common stock at $1.90 per share; options to purchase 1,400,000 shares of common stock at $0.25 per share; options to purchase 400,000 shares of common stock at $0.173 per share; options to purchase 400,000 shares of common stock at $0.168 per share, options to purchase 2,750,000 shares of common stock at $0.138 per share; and options to purchase 2,737,500 shares of common stock at $0.035 per share.
  3. N/A